Name: Latest research reports of Lupin Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Lupin Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer

2043.4000 55.40 (2.79%)

NSE Sep 12, 2025 15:31 PM

Volume: 1.6M

High volume today

Lupin Ltd.

07 Nov 2019

2043.40

2.79%

Lupin (ADD): Q2 a slight miss; US to improve in H2

Buy: Lupin Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Core Q2 EBITDA, normalised for licensing income, was a 5% miss at Rs 6bn (flat QoQ).

Lupin Ltd. is trading at high day volume of 1.6M.